drugset
drugset / Trial / NCT00418769

Bioavailability Study Comparing Two New Nilotinib Tablet Formulations to an Established Nilotinib Capsule Formulation in Healthy Volunteers

NCT00418769 ↗

Phase 1 Completed 24 enrolled Novartis Pharmaceuticals
RandomizedCrossoverOpen-labelTreatment

Summary

Bioavailability study comparing two new nilotinib tablet formulations to an established nilotinib capsule formulation in healthy volunteers

Timeline

Start
2006-06
Primary completion
2006-08
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Nilotinib Small molecule — —

Indications

No indication recorded.